Clinical Trial Update: The Cardioprotective Effect of Intralipid in Decreasing the Ischemic Insults During Off-pump Coronary Artery Revascularization [Phase 4]

View source ↗

Summary

Phase 4 trial update examining whether Intralipid provides cardioprotection by reducing ischemic insults during off-pump coronary revascularization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia-related Conditions
• Coronary Artery Disease
• Ischemia

Drugs mentioned

• Intralipid (intravenous lipid emulsion)

Snippet

Sponsor: Ain Shams University | Conditions: Anesthesia | Phase 4 | Status: COMPLETED